MSME (Udyam registered) Ministry of MSME
- Category
- Small (2024-25)
- Udyam number
- UDYAM-HR-06-0020012
VHL Pharmaceuticals Private Limited
VHL Pharmaceuticals Private Limited - pharma in New Delhi, Delhi, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹9.28 Cr
▲ 14% YoY
Net profit · FY 2025
₹10.32 Lakh
Net margin 1.1%
EBITDA · FY 2025
₹15.58 Lakh
EBITDA margin 1.7%
Authorised capital
₹25 Lakh
Registered with MCA
Paid-up capital
₹25 Lakh
Issued & subscribed
Company age
8 yrs
Est. 2018
Directors on board
3
As per MCA filings
Active GSTINs
1
GST registered
About VHL Pharmaceuticals Private Limited
Data last updated:
VHL Pharmaceuticals Private Limited is a private limited company based in New Delhi, Delhi, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 11 January 2018 and has been in existence for over 8 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U51909DL2018PTC328315. Its GSTIN is 06AAGCV2491R1ZL (Haryana).
The company has an authorised share capital of ₹25 Lakh and a paid-up capital of ₹25 Lakh. It is led by directors including Monika and Vikesh Grover.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 1st Floor House No. 1/9 Kunwar Singh Nagar Nangloi Near S.G.N Public School, New Delhi, Delhi, India – 110041.
As per the financials filed for FY 2025, the company reported a revenue of ₹9.28 Cr, a growth of 14% compared to the previous year. For the same year it recorded a net profit of ₹10.32 Lakh (net margin 1.1%) and EBITDA of ₹15.58 Lakh (EBITDA margin 1.7%). Revenue has grown at a compounded annual rate (CAGR) of 29% over three years and 179% over five years.
VHL Pharmaceuticals Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-HR-06-0020012). The current compliance status is marked as compliant by the Registrar of Companies.
Company details
CIN U51909DL2018PTC328315
Registration Number 328315
Incorporation Date 11 January 2018
ROC Delhi
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Small
Udyam Registration UDYAM-HR-06-0020012
Key People
Monika Director Vikesh Grover Director Pankaj Director Recognitions & Rankings of VHL Pharmaceuticals
Contact details
VHL Pharmaceuticals Private Limited's registered office is in New Delhi, Delhi. Its e-mail address is in the company report.
- Email
- Registered Address1st Floor House No. 1/9 Kunwar Singh Nagar Nangloi Near S.G.N Public School, New Delhi, Delhi, India – 110041
- IndustryPharma, Drug Formulation & Development
To see the full contact details of VHL Pharmaceuticals Private Limited, buy the company report.
Comprehensive company report
VHL Pharmaceuticals Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of VHL Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of VHL Pharmaceuticals Private Limited, buy the company report.
Financials of VHL Pharmaceuticals Private Limited
FY 2025 filings availableVHL Pharmaceuticals Private Limited reported revenue of ₹9.28 Cr (up 14% YoY) for FY 2025.
Revenue · FY 2025
₹9.28 Cr ▲ 14%
Net profit · FY 2025
₹10.32 Lakh margin 1.1%
EBITDA · FY 2025
₹15.58 Lakh margin 1.7%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 14%
3 years · compounded
▲ 29%
5 years · compounded
▲ 179%
EBITDA CAGR growth
1 year
▲ 49%
3 years · compounded
▲ 131%
5 years · compounded
▲ 97%
Revenue has grown at a compounded annual rate (CAGR) of 179% over five years, including 14% growth in the latest year. EBITDA rose 49% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹15.58 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹10.32 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 1.7% | ||||
| Net Profit Margin | 1.1% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of VHL Pharmaceuticals Private Limited, buy the company report.
Board of directors of VHL Pharmaceuticals Private Limited
VHL Pharmaceuticals has 3 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Monika | Director | 25 Feb 2021 | 5 Years 8 Months | Current |
| Vikesh Grover | Director | 11 Jan 2018 | 8 Years 9 Months | Current |
| Pankaj Also directs: Resurge Life Sciences Private Limited | Director | 11 Jan 2018 | 8 Years 9 Months | Current |
Legal cases
No court or tribunal cases involving VHL Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for VHL Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
VHL Pharmaceuticals has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 06AAGCV2491R1ZL | Haryana | Active | 07 Apr 2021 |
To see the full GST registrations and return filing status of VHL Pharmaceuticals Private Limited, buy the company report.
Recent activity
VHL Pharmaceuticals Private Limited has 4 board changes on record since 2018: 3 appointments and 1 cessation. The latest: Pankaj ceased to be Director on 05 Mar 2021.
AGM
Vhl Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Vhl Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi I.
Ceased
Pankaj ceased to be Director.
Appointed
Monika was appointed as Director.
Appointed
Pankaj was appointed as Director.
Appointed
Vikesh Grover was appointed as Director.
Incorporation
11 Jan 2018
Vhl Pharmaceuticals Private Limited was registered on 11 Jan 2018 with Roc Delhi I & aged 8 years 9 months as per MCA records.
Frequently asked questions
VHL Pharmaceuticals is an active private limited company based in New Delhi, Delhi, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 11 January 2018 (8+ years old) and is registered under CIN U51909DL2018PTC328315.
VHL Pharmaceuticals has 3 current directors:
- Monika - Director
- Vikesh Grover - Director
- Pankaj - Director
The latest financial statements of VHL Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2018 are in the company report.
The GSTIN of VHL Pharmaceuticals is 06AAGCV2491R1ZL, registered in Haryana.
The CIN (Corporate Identification Number) of VHL Pharmaceuticals is U51909DL2018PTC328315. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
VHL Pharmaceuticals was incorporated on 11 January 2018, making it 8+ years old. It is registered with the Registrar of Companies, Delhi.
Pankaj ceased to be Director on 05 Mar 2021. Monika was appointed as Director on 25 Feb 2021. Pankaj was appointed as Director on 11 Jan 2018. VHL Pharmaceuticals has 4 board changes on record in total.
Yes, VHL Pharmaceuticals is registered as a small enterprise under Udyam registration (number: UDYAM-HR-06-0020012).
The registered office of VHL Pharmaceuticals is at 1st Floor House No. 19 Kunwar Singh Nagar Nangloi Near S.G.N Public School, New Delhi, Delhi, India – 110041.
VHL Pharmaceuticals operates in the pharma industry, in the drug formulation and development segment.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages